HCV Test24 Jun 2021 10:43
The Genedrive® HCV ID kit has started to gain commercial traction since the start 2020. The full year sales to June 2020 had been predicated on growing sales across various end markets, in part supported by gaining WHO qualified status (which we now have), during the second half of the Company's financial year.
Unsurprisingly, with countries increasingly in lock-down and healthcare systems focused on coronavirus testing and treatment, it is now impossible to predict the duration, speed, and impact of the pandemic on the HCV business. The Company continues to support its partners with test supply and technical support.
Sales should start to pick up as lockdown eases around the world. Could be some big contracts to come.